Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations
- 31 May 2009
- journal article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 34 (2), 199-211
- https://doi.org/10.1016/j.nbd.2008.12.011
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Activating a RepressorScience, 2008
- MeCP2, a Key Contributor to Neurological Disease, Activates and Represses TranscriptionScience, 2008
- The regulation of dendritic arbor development and plasticity by glutamatergic synaptic input: a review of the synaptotrophic hypothesisThe Journal of Physiology, 2008
- MeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse NumberNeuron, 2007
- The neuronal Arf GAP centaurin α1 modulates dendritic differentiationJournal of Cell Science, 2007
- Transient receptor potential channels as novel effectors of brain-derived neurotrophic factor signaling: Potential implications for Rett syndromePharmacology & Therapeutics, 2007
- Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndromeProceedings of the National Academy of Sciences of the United States of America, 2006
- BDNF increases release probability and the size of a rapidly recycling vesicle pool within rat hippocampal excitatory synapsesThe Journal of Physiology, 2006
- Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndromeHuman Molecular Genetics, 2006
- The impact of MECP2 mutations in the expression patterns of Rett syndrome patientsHuman Genetics, 2004